In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 84102-69-2, name is Ethyl (5-bromobenzofuran)-2-carboxylate, introducing its new discovery. Product Details of 84102-69-2
This invention relates to compounds which are IP receptor antagonists and which are represented by Formula (I): 1wherein G2 is a heteroaryl group containing one or two nitrogen atoms substituted with a carboxylic acid group, said heteroaryl ring containing one or two nitrogen atoms, and G1 is as defined in the specification; or individual isomers, racemic or non-racemic mixtures of isomers, or pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds, methods for their use as therapeutic agents, and methods of preparation thereof.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 84102-69-2, and how the biochemistry of the body works.Product Details of 84102-69-2
Reference：
Benzofuran – Wikipedia,
Benzofuran | C8H4029O – PubChem